GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM246090
Query DataSets for GSM246090
Status
Public on Jun 04, 2008
Title
Cervical cancer cell line, HT-3
Sample type
RNA
Source name
Cervical cancer cell line, HT-3
Organism
Homo sapiens
Characteristics
Cell line
Biomaterial provider
ATCC
Treatment protocol
none
Growth protocol
none
Extracted molecule
total RNA
Extraction protocol
TRIzol extraction
Label
biotin
Label protocol
Affymetrix protocol
Hybridization protocol
Affymetrix protocol
Scan protocol
Affymetrix protocl
Description
Cervical cancer cell line
Data processing
GCOS
Submission date
Dec 02, 2007
Last update date
Sep 01, 2016
Contact name
Murty Vundavalli
E-mail(s)
[email protected]
Phone
(212) 851-4621
Fax
(212) 305-5498
Organization name
Columbia University Medical Center
Department
Pathology
Lab
Cancer Cytogenetics
Street address
1130 St Nicholas Ave
City
New York
State/province
NY
ZIP/Postal code
10032
Country
USA
Platform ID
GPL96
Series (1)
GSE9750
Identification of gene expression profiles in cervical cancer
Relations
Reanalyzed by
GSE86363
Data table header descriptions
ID_REF
VALUE
Signal
Data table
ID_REF
VALUE
AFFX-BioB-5_at
138.5
AFFX-BioB-M_at
251.5
AFFX-BioB-3_at
160.2
AFFX-BioC-5_at
595.1
AFFX-BioC-3_at
435.1
AFFX-BioDn-5_at
760.5
AFFX-BioDn-3_at
2881.5
AFFX-CreX-5_at
5041.2
AFFX-CreX-3_at
7073.1
AFFX-DapX-5_at
0.8
AFFX-DapX-M_at
4
AFFX-DapX-3_at
1.8
AFFX-LysX-5_at
3
AFFX-LysX-M_at
19.7
AFFX-LysX-3_at
3.7
AFFX-PheX-5_at
0.5
AFFX-PheX-M_at
0.4
AFFX-PheX-3_at
10
AFFX-ThrX-5_at
1.6
AFFX-ThrX-M_at
9.1
Total number of rows:
22283
Table truncated, full table size
348 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM246090.CEL.gz
3.5 Mb
(ftp)
(http)
CEL
Processed data included within Sample table
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|